502 articles across injectables, lasers, body contouring, skin therapeutics, and provider safety.
Why professional diagnosis is crucial before skin tag removal. Learn about dermatologist methods, costs, and the serious risks of OTC kits highlighted by the FDA.
FDA warning letters target sellers of semaglutide and retatrutide labeled 'for research use only'. Injecting these unapproved chemicals carries severe clinical and legal…
The FDA's April 2026 warning letter to a Texas med spa marks the first time a medical spa has been cited under the DSCSA. Sourcing, records, and unit-reconciliation…
While key parts of MoCRA are active, several rules remain pending, delayed, or withdrawn in 2026. An analysis of the FDA adverse-event database reveals a…
An evidence-based safety and regulatory review of unapproved fat-dissolving injections (Aqualyx, Lipo Lab, compounded PCDC) versus FDA-approved Kybella, analyzing FAERS…
An evidence-based safety and regulatory review of IV glutathione for skin lightening, analyzing FDA compounding concerns, foreign regulatory bans, and FAERS data.
An evidence-based safety and regulatory review of microblading and permanent makeup (PMU), analyzing FDA cosmetic adverse events, ink recalls, and infection risks.
A clinical safety guide to Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL), covering symptoms, textured implant recalls, FDA data, and NCCN treatment…
Can you trust ChatGPT or Google AI Overviews for cosmetic advice? Learn the science behind AI visibility bias, real clinical accuracy rates, and how to verify AI…
A comprehensive dermatological guide to diagnosing and treating infraorbital dark circles based on their root cause: pigment, volume loss, visible vessels, or structural…